Clinical Trial Update: A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of ASP1941 in adults with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin and sitagl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ASP1941

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED